Relmada Therapeutics RLMD
NASDAQ RLMD
$4.27 +0.13 (+3.14%)
At close: Nov 10, 2026 · 4:00 PM EST

Relmada Therapeutics (RLMD) Assets (2012 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) Assets (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Relmada Therapeutics 473.10 Mn -85.48 Mn - 219.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 219.06 Mn
Mar 31, 2026 235.36 Mn
Dec 31, 2025 94.00 Mn
Sep 30, 2025 14.88 Mn
Jun 30, 2025 21.12 Mn
Mar 31, 2025 27.68 Mn
Dec 31, 2024 45.82 Mn
Sep 30, 2024 55.72 Mn
Jun 30, 2024 71.03 Mn
Mar 31, 2024 84.41 Mn
Dec 31, 2023 97.55 Mn
Sep 30, 2023 109.15 Mn
Jun 30, 2023 122.04 Mn
Mar 31, 2023 135.57 Mn
Dec 31, 2022 152.91 Mn
Sep 30, 2022 187.12 Mn
Jun 30, 2022 215.77 Mn
Mar 31, 2022 225.81 Mn
Dec 31, 2021 223.33 Mn
Sep 30, 2021 90.93 Mn
API Access

Relmada Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=RLMD&period=max&api_key=YOUR_API_KEY